TipRanks
Go Ultimate55% OFF

Labixiaoxin Snacks Group Ltd. (1262) AI Stock Analysis

HK:1262

Labixiaoxin Snacks Group Ltd.

(HKEX:1262)

Select Model
Rating:55Neutral
Price Target:HKD 4.00â–¼(-3.03% Downside)
Action:reiterated
Date:08/29/26

Moderate score driven by mixed financial results with revenue growth but balance sheet risks, supported by positive technical momentum despite high valuation.

Positive Factors
Steady Revenue GrowthSustained revenue expansion indicates improving demand and greater operating scale for the branded snack business. If maintained, this growth can strengthen distribution economics, support fixed-cost absorption, and provide a foundation for rebuilding profitability over the next several quarters.
Negative Factors
High and Rising LeverageHigh and rising leverage leaves the company more exposed to earnings volatility and reduces financial flexibility. Debt claims a larger share of the capital structure while the equity base has declined, making it harder to absorb setbacks, fund growth internally, or reduce obligations without stronger cash generation.

Labixiaoxin Snacks Group Ltd. (1262) vs. iShares MSCI Hong Kong ETF (EWH)

-25%0%25%50%75%100%125%150%HK:1262+122.97%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 986.91M
Dividend Yield
―
Average Volume (3M)
54.47K
Price to Earnings (P/E)
-101.5
Beta (1Y)
0.69
Revenue Growth
26.54%
EPS Growth
82.47%
Country
Hong Kong
Employees
960
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

Labixiaoxin Snacks Group Ltd. Business Overview & Revenue Model

Company Description

Labixiaoxin Snacks Group Limited, an investment holding entity, specializes in the production and sale of a diverse array of snack items within the People's Republic of China. Its extensive product portfolio includes various types of jellies, such as...

How the Company Makes Money

The company primarily makes money by selling packaged snack products, generating revenue from (i) sales of branded snack foods to distributors/wholesalers and (ii) sales to retail customers through various sales channels (e.g., supermarkets, convenie...

Labixiaoxin Snacks Group Ltd. Financial Statement Overview

Summary

Steady revenue growth offset by volatile profitability, margin pressure, high leverage, and negative free cash flows.

Income Statement

55Neutral

Balance Sheet

40Negative

Cash Flow

50Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.08B969.81M866.67M764.38M684.26M648.07M
Gross Profit277.87M266.37M234.62M218.94M244.19M224.28M
EBITDA46.89M63.86M-30.01M-46.04M658.00K77.26M
Net Income-8.34M11.85M-93.46M-104.75M-75.33M-65.20M
Balance Sheet
Total Assets1.07B872.69M793.84M810.91M977.31M1.29B
Cash, Cash Equivalents and Short-Term Investments39.43M76.83M52.50M44.32M71.88M80.57M
Total Debt518.94M524.70M456.40M451.27M512.44M565.59M
Total Liabilities764.26M646.22M579.32M588.35M650.00M887.41M
Stockholders Equity305.30M226.47M214.52M222.56M327.31M402.64M
Cash Flow
Free Cash Flow34.40M-50.57M-34.23M55.42M-4.98M-156.86M
Operating Cash Flow124.02M33.58M31.53M88.64M15.46M-135.29M
Investing Cash Flow-89.28M-84.15M-65.54M-32.89M55.94M113.42M
Financing Cash Flow-43.42M74.23M42.19M-83.31M-80.09M-156.41M

Labixiaoxin Snacks Group Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price4.13

Price Trends

50DMA3.35Positive
100DMA3.12Positive
200DMA3.37Positive

Market Momentum

MACD0.26Negative
RSI78.94Negative
STOCH82.11Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1262, the sentiment is Positive. The current price of 4.13 is above the 20-day moving average (MA) of 3.54, above the 50-day MA of 3.35, and above the 200-day MA of 3.37, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 78.94 is Negative, neither overbought nor oversold. The STOCH value of 82.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1262.

Labixiaoxin Snacks Group Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

HK:1262 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1475HK:147575OutperformHKD 6.56B18.639.07%2.52%1.36%85.49%
HK:9985HK:998571OutperformHKD 16.03B9.3319.58%5.68%13.32%24.42%
HK:0151HK:015170OutperformHKD 32.92B5.7825.72%3.82%5.80%-9.69%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
HK:0322HK:032257NeutralHKD 71.31B12.7833.44%3.64%3.53%17.26%
HK:1262HK:126255NeutralHKD 986.91M-101.45-3.14%―26.54%82.47%
HK:1458HK:145853NeutralHKD 1.89B11.154.01%9.84%19.12%-12.12%

* Consumer Defensive Sector Average

Performance Comparison

-50%0%50%100%HK:1262HK:0151HK:0322HK:9985HK:1458HK:1475Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:1262 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:1262Labixiaoxin Snacks Group Ltd.4.132.27122.97%
HK:0151Want Want China2.83-2.09-42.54%
HK:0322Tingyi (Cayman Islands) Holding Corp12.652.5024.68%
HK:9985Weilong Delicious Global Holdings Limited6.59-4.08-38.24%
HK:1458Zhou Hei Ya International Holdings Company Limited0.92-0.82-47.29%
HK:1475Nissin Foods Co., Ltd.6.29-0.18-2.75%

Labixiaoxin Snacks Group Ltd. Corporate Events

Labixiaoxin Snacks Grows Revenue but Swings to Interim Loss on Rising Costs

Aug 28, 2026

Labixiaoxin Snacks Group Limited reported a solid increase in revenue for the six months ended 30 June 2026, with sales rising 21.8% year-on-year to RMB628.5 million and gross profit up 8.7% to RMB143.0 million, though gross margin slipped to 22.8%....

Labixiaoxin Snacks Schedules Board Meeting to Review Interim Results and Potential Dividend

Aug 17, 2026

Labixiaoxin Snacks Group Limited has called a board meeting for 28 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider whether to recommend the payment of an interim dividend, sign...

Labixiaoxin Snacks flags higher revenue but swings to interim loss

Aug 14, 2026

Labixiaoxin Snacks Group Ltd. has warned investors that, despite an expected rise in revenue to about RMB628 million for the six months ended 30 June 2026 from RMB516 million a year earlier, it anticipates a swing to a net loss of roughly RMB18 milli...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 29, 2026